1365 related articles for article (PubMed ID: 26073595)
1. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S
Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction.
Röger S; Rudic B; Akin I; Shchetynska-Marinova T; Fastenrath F; Tülümen E; Liebe V; El-Battrawy I; Baumann S; Kuschyk J; Borggrefe M
Clin Cardiol; 2018 Apr; 41(4):518-524. PubMed ID: 29697870
[TBL] [Abstract][Full Text] [Related]
3. Concomitant Use of the Subcutaneous Implantable Cardioverter Defibrillator and a Permanent Pacemaker.
Huang J; Patton KK; Prutkin JM
Pacing Clin Electrophysiol; 2016 Nov; 39(11):1240-1245. PubMed ID: 27734502
[TBL] [Abstract][Full Text] [Related]
4. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
[TBL] [Abstract][Full Text] [Related]
5. Sudden Death in Patients With Cardiac Implantable Electronic Devices.
Tseng ZH; Hayward RM; Clark NM; Mulvanny CG; Colburn BJ; Ursell PC; Olgin JE; Hart AP; Moffatt E
JAMA Intern Med; 2015 Aug; 175(8):1342-50. PubMed ID: 26098676
[TBL] [Abstract][Full Text] [Related]
6. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
[TBL] [Abstract][Full Text] [Related]
7. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
8. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.
Olde Nordkamp LR; Knops RE; Bardy GH; Blaauw Y; Boersma LV; Bos JS; Delnoy PP; van Dessel PF; Driessen AH; de Groot JR; Herrman JP; Jordaens LJ; Kooiman KM; Maass AH; Meine M; Mizusawa Y; Molhoek SG; van Opstal J; Tijssen JG; Wilde AA
Am Heart J; 2012 May; 163(5):753-760.e2. PubMed ID: 22607851
[TBL] [Abstract][Full Text] [Related]
10. [Device-device interaction].
Johnson V; Hamm CW; Schmitt J
Herzschrittmacherther Elektrophysiol; 2019 Jun; 30(2):183-190. PubMed ID: 30989336
[TBL] [Abstract][Full Text] [Related]
11. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
[TBL] [Abstract][Full Text] [Related]
12. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator.
Tjong FVY; Brouwer TF; Koop B; Soltis B; Shuros A; Schmidt B; Swackhamer B; Quast AEB; Wilde AAM; Burke MC; Knops RE
JACC Clin Electrophysiol; 2017 Dec; 3(13):1487-1498. PubMed ID: 29759829
[TBL] [Abstract][Full Text] [Related]
13. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
[TBL] [Abstract][Full Text] [Related]
14. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
[TBL] [Abstract][Full Text] [Related]
15. Inappropriate shock incidence in patients with subcutaneous implantable cardioverter-defibrillators with concomitant cardiac implantable electronic devices: A single-center cohort study.
Okazaki M; Sahashi Y; Nagase T; Inoue K; Sekiguchi Y; Nitta J; Shinoda S; Shimizu S; Kuroki M; Isobe M; Mihara T
Pacing Clin Electrophysiol; 2024 Jan; 47(1):131-138. PubMed ID: 38010718
[TBL] [Abstract][Full Text] [Related]
16. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
18. Defibrillators: Selecting the Right Device for the Right Patient.
Al-Khatib SM; Friedman P; Ellenbogen KA
Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
[TBL] [Abstract][Full Text] [Related]
19. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.
Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M
Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
